Canadian public drug plan spending grew by $3.4 billion over 5 years, driven by use of higher-cost drugs
Imported from official source
The latest edition of the PMPRB CompassRx report shows that prescription drug expenditure for public drug plans grew by 7.4% in 2022/23 to reach $14.1 billion, compared to $13.2 billion in 2021/22.
This version
- Version
- 1 of 1
- Recorded
- October 03, 2026 20:43
- Change
- Initial
- Content hash
a9eca80df6877d9e33add5809af02914- All versions
- Revision history